OTC Recalls: Children's Allergy Tablets, Eye Care Products
Executive Summary
Standard Homeopathic's recent recall of its Hyland’s teething tablets was designated class I, indicating a reasonable probability of serious adverse health consequences or death, FDA notes in May 31 update to its recalls database.
You may also be interested in...
Teething Tablets, Toothpaste Recalls: Consumer Health Industry News Roundup
Standard Homeopathic recalls Hyland's teething products; ACT enters children's toothpaste market; Sensodyne toothpaste recalled.
US FDA Manufacturing Enforcement In Brief: Recent Warning Letters And Import Alerts
Recent US FDA drug GMP warning letters featured findings of lax contamination controls and data integrity issues at firms in China, India, Japan, Illinois and East Texas. Meanwhile, FDA hit six plants in India and China with drug GMP import alerts.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.